Duscha, Brian D., Lucy W. Piner, Mahesh P. Patel, Lawrence E. Crawford, William S. Jones, Manesh R. Patel, and William E. Kraus. “Effects of a 12-Week mHealth Program on FunctionalCapacity and Physical Activity in Patients With PeripheralArtery Disease.” Am J Cardiol 122, no. 5 (September 1, 2018): 879–84. https://doi.org/10.1016/j.amjcard.2018.05.018.
Griffin, Andrew, Ann Marie Navar, Lawrence Crawford, Joseph Mammarappallil, and Lynne Hurwitz Koweek. “A case of spontaneous coronary artery dissection diagnosed by coronary computed tomography angiography.” J Cardiovasc Comput Tomogr 12, no. 1 (January 2018): 88–89. https://doi.org/10.1016/j.jcct.2017.09.005.
Fauchier, Laurent, Nicola Greenlaw, Roberto Ferrari, Ian Ford, Kim M. Fox, Jean-Claude Tardif, Michal Tendera, Ph Gabriel Steg, and Ph Gabriel CLARIFY Investigators. “Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.” Plos One 10, no. 4 (2015): e0125164. https://doi.org/10.1371/journal.pone.0125164.
Goldschmid, P. J., N. Lopes, L. E. Crawford, and R. C. Becker. “Atherothrombosis and coronary artery disease,” December 1, 2007, 629–55. https://doi.org/10.1016/B978-012369367-9/50797-7.
Waters, Richard E., David E. Kandzari, Harry R. Phillips, Lawrence E. Crawford, and Michael H. Sketch. “Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.” Catheter Cardiovasc Interv 65, no. 4 (August 2005): 520–24. https://doi.org/10.1002/ccd.20428.
Dong, Chunming, Lawrence E. Crawford, and Pascal J. Goldschmidt-Clermont. “Endothelial progenitor obsolescence and atherosclerotic inflammation.” J Am Coll Cardiol 45, no. 9 (May 3, 2005): 1458–60. https://doi.org/10.1016/j.jacc.2005.02.030.
Weston, Patrick, John H. Alexander, Manesh R. Patel, Charles Maynard, Lawrence Crawford, and Galen S. Wagner. “Hand-held echocardiographic examination of patients with symptoms of acute coronary syndromes in the emergency department: the 30-day outcome associated with normal left ventricular wall motion.” Am Heart J 148, no. 6 (December 2004): 1096–1101. https://doi.org/10.1016/j.ahj.2004.05.026.
Blazing, Michael A., and Lawrence E. Crawford. “Enhanced External Counterpulsation (EECP): enough evidence to support this and the next wave?” American Heart Journal 146, no. 3 (September 2003): 383–84. https://doi.org/10.1016/s0002-8703(03)00252-7.
Crawford, L. E. “Experience with enhanced external counterpulsation (EECP®) in coronary artery disease.” Today’S Therapeutic Trends 20, no. 3 (September 1, 2002): 243–52.
Arora, Rohit R., Tony M. Chou, Diwakar Jain, Bruce Fleishman, Lawrence Crawford, Thomas McKiernan, Richard Nesto, Carol Estwing Ferrans, and Susan Keller. “Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation.” J Investig Med 50, no. 1 (January 2002): 25–32. https://doi.org/10.2310/6650.2002.33514.